/Companies

EndoGastric Solutions

San Mateo, US · Founded 1987 · Delaware corporation · 3,551 employees on LinkedIn · 13 known investors

Find your way into EndoGastric Solutions

Sign up to see every warm intro you have to EndoGastric Solutions

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the EndoGastric Solutions team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.

Founders & leadership

PM
Philip MacdonaldExecutive
LB
Louis BaldinoExecutive
LL
Lilip LauExecutive
JDJosh DeFonzo
Josh DeFonzoVice President of Sales and Marketing; Interim President2013–2014Josh DeFonzo is an executive in health technology with experience in product development, business model creation, and go-to-market strategy across surgical and gastroenterology specialties. He has worked on clinical trial design and healthcare reimbursement strategies for minimally invasive medical devices.

Board

MCMichael Carusi
Michael CarusiBoard directorManaging Partner at Lightstone Ventures
AM
Arda MinocherhomjeeBoard director
BABrent Ahrens
Brent AhrensBoard directorGeneral Partner at Canaan Partners
JDJordan Davis
Jordan DavisBoard directorManaging Partner and Co-founder at Radius Ventures
LW
Lee Wrubel, M.D.Board director
GJ
Guy JordanBoard director
FL
Floyd Loop, M.D.Board director
RM
Robert Michael KleineBoard director

Investors · 13

Also in the syndicate · 4

Advanced Technology Ventures (ATV)Canepa HealthcareChicago Growth PartnersCRG

Funding

SEC filings, press & company announcements

$110.6M disclosed across 6 of 9 rounds · 2012–2020

▶$27MraisedDec 2021 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Louis BaldinoExecutive Officer, Director
  • Darren CrowExecutive Officer
  • Michael CarusiDirector
  • Theodore StephensExecutive Officer
  • Brent AhrensDirector
  • Alejandro SanchezDirector
  • John GillingsDirector
  • Michael BurkeExecutive Officer
  • Kunal PaymasterDirector
  • Martin ReidExecutive Officer
Offering amount
$45M
Amount sold
$27M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedJun 2019 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arda MinocherhomjeeDirector
  • Uri GeigerDirector
  • Theodore StephensExecutive Officer
  • Martin ReidExecutive Officer
  • Darren CrowExecutive Officer
  • Michael BurkeExecutive Officer
  • Louis BaldinoExecutive Officer, Director
  • Philip MacdonaldExecutive Officer
  • Jordan DavisDirector
  • Brent AhrensDirector
  • Kunal PaymasterDirector
  • Alejandro SanchezDirector
  • Michael CarusiDirector
Offering amount
$40.6M
Amount sold
$40.6M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedMay 2015 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CarusiDirector
  • Scott WardDirector
  • Arda MinocherhomjeeDirector
  • Philip MacdonaldExecutive Officer
  • Brent AhrensDirector
  • Jordan DavisDirector
  • Lee Wrubel, M.D.Director
  • Louis BaldinoExecutive Officer, Director
Offering amount
$25M
Amount sold
$10M
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedApr 2015 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CarusiDirector
  • Scott WardDirector
  • Skip BaldinoExecutive Officer, Director
  • Arda MinocherhomjeeDirector
  • Jordan DavisDirector
  • Brent AhrensDirector
  • Philip MacdonaldExecutive Officer
  • Lee Wrubel, M.D.Director
Offering amount
$1.5M
Amount sold
$1.3M
Minimum investment
$1.8K
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.6MraisedMay 2014 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guy JordanDirector
  • Scott WardDirector
  • Robert Michael KleineDirector
  • Arda MinocherhomjeeDirector
  • Brent AhrensDirector
  • Lilip LauExecutive Officer
  • Jordan DavisDirector
  • Lee Wrubel, M.D.Director
  • Josh DeFonzoExecutive Officer
  • Skip BaldinoExecutive Officer
  • Floyd Loop, M.D.Director
  • Michael CarusiDirector
Offering amount
$30.7M
Amount sold
$30.6M
Minimum investment
$33.9K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedApr 2014 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael CarusiDirector
  • Lilip LauExecutive Officer
  • Scott WardDirector
  • Guy JordanDirector
  • Floyd Loop, M.D.Director
  • Josh DeFonzoExecutive Officer
  • Arda MinocherhomjeeDirector
  • Brent AhrensDirector
  • Lee Wrubel, M.D.Director
  • Jordan DavisDirector
  • Robert Michael KleineDirector
Offering amount
$1M
Amount sold
$1M
Minimum investment
$3.2K
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through EndoGastric Solutions went on to found or lead other companies.

In the news

Frequently asked questions

What does EndoGastric Solutions do?
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.
Who are EndoGastric Solutions's investors?
EndoGastric Solutions's investors include Accelmed Partners, Canaan Partners, Evidity Health Capital, Lightstone Ventures, VCFA Group, Advanced Technology Ventures, De Novo Ventures, FOUNDATION MEDICAL PARTNERS and 1 more.
How much funding has EndoGastric Solutions raised?
EndoGastric Solutions has disclosed $110.6M raised across 6 of its 9 known rounds.
Where is EndoGastric Solutions headquartered?
EndoGastric Solutions is headquartered in San Mateo, US.